EUVIMEDEUVIMED entdecken
Crossref

TMEM106B deficiency exacerbates α-synuclein aggregation in Parkinson’s disease

Lanxia Meng, Congcong Liu, Meihui Li, Huangchuan Gong, Xiaoling Gu, Wenxuan Zou iD, Han Liu, Hanying Teng, Jing Xiong, Zhentao Zhang iD

Brain · 07.09.2026 · 149 (9) · 3150-3165

DOI: 10.1093/brain/awag065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 17.02.2026. Verfasst von Lanxia Meng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Renmin Hospital of Wuhan University, Wuhan 430060, China. Hauptthemen laut MEDLINE: alpha-Synuclein, Membrane Proteins, Parkinson Disease, Nerve Tissue Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Innovative Research Groups of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease is an age-related neurodegenerative disease that is characterized by the deposition of α-synuclein aggregates in the brain. Nevertheless, the molecular mechanisms that regulate α-synuclein aggregation have not yet been identified fully. TMEM106B is a lysosomal transmembrane protein that has been reported to be associated with brain ageing and neurodegenerative diseases, including Parkinson’s disease. Here we show that TMEM106B is reduced in the brains of patients with Parkinson’s disease. Knockout of Tmem106b increases the formation of α-synuclein aggregates in primary neurons and mouse brains. TMEM106B deficiency results in impaired lysosomal acidification, lipid metabolism disorders and lipid droplet deposition in neurons. Interestingly, lipid droplets promote α-synuclein aggregation, resulting in the formation of α-synuclein fibrils with enhanced seeding activity and neurotoxicity in comparison to α-synuclein fibrils formed in the absence of lipid droplets. TMEM106B deficiency also leads to retardation of α-synuclein degradation by reducing the enzymatic activity of the lysosomal protease cathepsin D. Taken together, these results indicate that TMEM106B deficiency contributes to Parkinson’s disease pathogenesis by accelerating α-synuclein aggregation and halting α-synuclein degradation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinMembrane ProteinsParkinson DiseaseNerve Tissue ProteinsProtein Aggregation, PathologicalAnimalsHumansMiceMice, KnockoutNeuronsBrainLysosomesMice, Inbred C57BLMale

Stichwörter der Autor:innen

Parkinson’s diseaselipid metabolismneurodegenerative diseasetransmembrane protein 106B (TMEM106B)

Substanzen

alpha-SynucleinMembrane ProteinsNerve Tissue ProteinsTmem106b protein, mouseTMEM106B protein, human

Autor:innen und Institutionen

  • Department of Neurology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • College of Life Sciences, Wuhan University, Wuhan 430072, China.
  • TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan 430072, China.

ORCID-Profile: Wenxuan Zou, Zhentao Zhang

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Innovative Research Groups of Hubei Province
  • Natural Science Foundation Innovation Development Joint Fund Projects

Zitieren

APA

Meng, L., Liu, C., Li, M., Gong, H., Gu, X., Zou, W., Liu, H., Teng, H., Xiong, J., & Zhang, Z. (2026). TMEM106B deficiency exacerbates α-synuclein aggregation in Parkinson’s disease. Brain, 149(9), 3150-3165. https://doi.org/10.1093/brain/awag065

Vancouver

Meng L, Liu C, Li M, Gong H, Gu X, Zou W, et al. TMEM106B deficiency exacerbates α-synuclein aggregation in Parkinson’s disease. Brain. 2026;149(9):3150-3165. doi:10.1093/brain/awag065

BibTeX
@article{Meng2026,
  author = {Meng, Lanxia and Liu, Congcong and Li, Meihui and Gong, Huangchuan and Gu, Xiaoling and Zou, Wenxuan and Liu, Han and Teng, Hanying and Xiong, Jing and Zhang, Zhentao},
  title = {TMEM106B deficiency exacerbates α-synuclein aggregation in Parkinson’s disease},
  journal = {Brain},
  year = {2026},
  volume = {149},
  number = {9},
  pages = {3150--3165},
  doi = {10.1093/brain/awag065}
}
Kostenlos starten →